ICU Medical, Inc. (ICUI)

Market Cap	3.32B
Revenue (ttm)	2.42B
Net Income (ttm)	-93.69M
Shares Out	24.61M
EPS (ttm)	-3.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	241,173
Open	130.72
Previous Close	132.15
Day's Range	130.72 - 136.03
52-Week Range	114.82 - 196.26
Beta	0.89
Analysts	Strong Buy
Price Target	196.75 (+45.86%)
Earnings Date	Aug 6, 2025

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 31, 1992
• Employees: 15,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ICUI
• Website: https://www.icumed.com

Financial Performance

In 2024, ICU Medical's revenue was $2.38 billion, an increase of 5.44% compared to the previous year's $2.26 billion. Losses were -$117.69 million, 296.9% more than in 2023.

Analyst Summary

According to 5 analysts, the average rating for ICUI stock is "Strong Buy." The 12-month stock price target is $196.75, which is an increase of 45.86% from the latest price.

Price Target

$196.75

(45.86% upside)

Analyst Consensus: Strong Buy